Juwon Kim, M.D. Ph.D.
Blood Res 2017; 52(4): 235-236Jieun Kim, M.D.
Blood Res 2017; 52(4): 237-239Sarita Pradhan, and Sima Chauhan
Blood Res 2017; 52(4): 240-240Ja Young Lee, and Hwa Jin Cho
Blood Res 2017; 52(4): 241-241Neha Nigam, and Chhagan Bihari
Blood Res 2017; 52(4): 242-242Jun Ho Yi, Seok Jin Kim, and Won Seog Kim
Blood Res 2017; 52(4): 243-253Jun Ho Jang, Ji Yoon Kim, Yeung-Chul Mun, Soo-Mee Bang, Yeon Jung Lim, Dong-Yeop Shin, Young Bae Choi, Ho-Young Yhim, Jong Wook Lee, Hoon Kook, and on the behalf of Korean Aplastic Anemia Working Party
Blood Res 2017; 52(4): 254-263Deependra Kumar Yadav, Anil Kumar Tripathi, Divya Gupta, Saurabh Shukla, Aloukick Kumar Singh, Ashutosh Kumar, Jyotsna Agarwal, and K. N. Prasad
Blood Res 2017; 52(4): 264-269Eun-Ji Choi, Jung Yong Hong, Dok Hyun Yoon, Jihoon Kang, Chan-Sik Park, Jooryung Huh, Eun Jin Chae, Yoonse Lee, Jin-Sook Ryu, and Cheolwon Suh
Blood Res 2017; 52(4): 270-275Jihoon Kang, Shinkyo Yoon, and Cheolwon Suh
Blood Res 2017; 52(4): 276-284
Overall survival and relapse-free survival of
Abbreviations: H, high-risk group; H-I, high-intermediate; L, low; L-I, low-intermediate.
|@|~(^,^)~|@|Overall survival and relapse-free survival according to
Abbreviations: H, high-risk group; H-I, high-intermediate; IPI, International Prognostic Index; L, low; L-I, low-intermediate; NCCN-IPI, National Comprehensive Cancer Network-International Prognostic Index; RFS, relapse-free survival.